These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 21687949

  • 1. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin J, Li WM, Liu HT, Wang YX.
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW, Wen F.
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [Abstract] [Full Text] [Related]

  • 3. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway.
    Huang P, Yu C, Liu XQ, Ding YB, Wang YX, He JL.
    Int J Mol Med; 2011 Oct; 28(4):579-87. PubMed ID: 21687933
    [Abstract] [Full Text] [Related]

  • 5. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 Oct; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 7. Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca²⁺ and caspase-dependent signaling pathways.
    Chen WJ, Yu C, Yang Z, He JL, Yin J, Liu HZ, Liu HT, Wang YX.
    Int J Oncol; 2012 Feb; 40(2):535-43. PubMed ID: 21971569
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S, Olivero M, Corà D, Di Renzo MF.
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [Abstract] [Full Text] [Related]

  • 10. The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.
    Shinagawa A, Yoshida Y, Kurokawa T, Horiuchi Y, Tsuyoshi H, Orisaka M, Sawamura Y, Kleinman HK, Kotsuji F.
    Int J Oncol; 2011 Dec; 39(6):1359-64. PubMed ID: 21935568
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M, Yan Y, Kortum RL, Stoeger SM, Sgagias MK, Lee K, Lewis RE, Cowan KH.
    Cancer Res; 2005 May 15; 65(10):3986-92. PubMed ID: 15899786
    [Abstract] [Full Text] [Related]

  • 13. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T.
    Int J Gynecol Cancer; 2012 Jul 15; 22(6):922-9. PubMed ID: 22672985
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y.
    Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518
    [Abstract] [Full Text] [Related]

  • 15. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
    Zhang Y, Qu X, Jing W, Hu X, Yang X, Hou K, Teng Y, Zhang J, Liu Y.
    Anticancer Drugs; 2009 Mar 01; 20(3):208-14. PubMed ID: 19396019
    [Abstract] [Full Text] [Related]

  • 16. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M.
    Biomed Pharmacother; 2009 Sep 01; 63(8):553-60. PubMed ID: 18571892
    [Abstract] [Full Text] [Related]

  • 17. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M.
    Cell Physiol Biochem; 2016 Sep 01; 39(1):242-52. PubMed ID: 27336949
    [Abstract] [Full Text] [Related]

  • 18. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E, Mills GB, Tsang BK.
    Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739
    [Abstract] [Full Text] [Related]

  • 19. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar 01; 38(3):158-61. PubMed ID: 12816691
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.